Therapeutic Solutions International Files Patent on Clinical Data Demonstrating Reduction of Inflammatory Cytokines Using NanoStilbene™
September 25, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) announced today filing of a patent covering novel clinical...
Therapeutic Solutions International Collaborates with Internationally Renowned Neurologist and NFL Charger Hall of Famer to Develop New Intellectual Property for Treatment of Chronic Traumatic Encephalopathy
September 19, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Files Patent and Generates Proof of Concept Data using NeuroStilbene for Prevention of Football Associated Brain Damage OCEANSIDE, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR...
Therapeutic Solutions International Completes Phase 1 Clinical Trial in Advanced Cancer Patients for Right to Try Access of its StemVacs Product for American Cancer Patients
September 04, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company to use Phase I Data of its Cancer Stem Cell Immunotherapy to Allow for use in the USA under President Donald Trump's Right to Try Law OCEANSIDE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) --...
Therapeutic Solutions International Recruits NFL Chargers Hall of Famer Wes Chandler to Lead NeuroStilbene for Chronic Traumatic Encephalopathy in Football Players
August 22, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company to Advance NeuroStilbene Product for High-Performance AthletesSusceptible to Head Injuries OCEANSIDE, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions...
Therapeutic Solutions International Reports Synergistic Enhancement of Ozone Therapy Efficacy in Prostate, Breast and Ovarian Cancer Cells by Pterostilbene
August 13, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Clinical Stage Cancer Immunotherapy Biotechnology Company Files Patent Expanding Uses of its Pterostilbene Based Product Pipeline OCEANSIDE, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR...
Therapeutic Solutions International Develops Microemulsion Formulation of Alpha Lipoic Acid for Intranasal Delivery
August 06, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Expands Product Pipeline in Neurodegenerative Arena OCEANSIDE, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI)...
Therapeutic Solutions International Recruits Internationally Recognized Cancer Immunotherapy Pioneer Dr. Francesco Marincola to Accelerate StemVacs and NanoStilbene Clinical Development
July 23, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Focuses on Non-Toxic Therapies Using Immune System to Selectively Kill Cancer Cells through Immunotherapy OCEANSIDE, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE --...
Therapeutic Solutions International, Inc., Releases Intranasal Formulation of Pterostilbene for Rapid Access to Blood-Brain Barrier
July 16, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Expands its Pterostilbene Based Portfolio into Brain Cancers OCEANSIDE, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC...
Therapeutic Solutions International, Inc., Appoints Juergen Winkler, MD, ABIHM to Scientific Advisory Board
July 09, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Pioneer of Functional Medicine Teams Up with Clinical Stage Biotechnology Company in Commercialization of Non-Toxic Immunotherapy OCEANSIDE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR...
Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™
July 02, 2018 09:17 ET
|
Therapeutic Solutions International, Inc.
Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally Administered OCEANSIDE, Calif., July 02, 2018 (GLOBE NEWSWIRE) --...